Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global market for Gene-based Advanced Therapy Medicinal is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Gene-based Advanced Therapy Medicinal market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Gene-based Advanced Therapy Medicinal market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Gene-based Advanced Therapy Medicinal market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Gene-based Advanced Therapy Medicinal market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Gene-based Advanced Therapy Medicinal players cover Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics and Alnylam Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Gene-based Advanced Therapy Medicinal market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Gene-based Advanced Therapy Medicinal market, with both quantitative and qualitative data, to help readers understand how the Gene-based Advanced Therapy Medicinal market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Gene-based Advanced Therapy Medicinal market and forecasts the market size by Type (Viral Gene Delivery System and Non-viral Gene Delivery System,), by Application (Neurological Diseases, Cancer and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Viral Gene Delivery System
Non-viral Gene Delivery System
Segmentation by application
Neurological Diseases
Cancer
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Chapter Introduction
Chapter 1: Scope of Gene-based Advanced Therapy Medicinal, Research Methodology, etc.
Chapter 2: Executive Summary, global Gene-based Advanced Therapy Medicinal market size and CAGR, Gene-based Advanced Therapy Medicinal market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Gene-based Advanced Therapy Medicinal revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Gene-based Advanced Therapy Medicinal revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Gene-based Advanced Therapy Medicinal market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and Sunway Biotech, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gene-based Advanced Therapy Medicinal Market Size 2017-2028
2.1.2 Gene-based Advanced Therapy Medicinal Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Gene-based Advanced Therapy Medicinal Segment by Type
2.2.1 Viral Gene Delivery System
2.2.2 Non-viral Gene Delivery System
2.3 Gene-based Advanced Therapy Medicinal Market Size by Type
2.3.1 Gene-based Advanced Therapy Medicinal Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2017-2022)
2.4 Gene-based Advanced Therapy Medicinal Segment by Application
2.4.1 Neurological Diseases
2.4.2 Cancer
2.4.3 Other
2.5 Gene-based Advanced Therapy Medicinal Market Size by Application
2.5.1 Gene-based Advanced Therapy Medicinal Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2017-2022)
3 Gene-based Advanced Therapy Medicinal Market Size by Player
3.1 Gene-based Advanced Therapy Medicinal Market Size Market Share by Players
3.1.1 Global Gene-based Advanced Therapy Medicinal Revenue by Players (2020-2022)
3.1.2 Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Players (2020-2022)
3.2 Global Gene-based Advanced Therapy Medicinal Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Gene-based Advanced Therapy Medicinal by Regions
4.1 Gene-based Advanced Therapy Medicinal Market Size by Regions (2017-2022)
4.2 Americas Gene-based Advanced Therapy Medicinal Market Size Growth (2017-2022)
4.3 APAC Gene-based Advanced Therapy Medicinal Market Size Growth (2017-2022)
4.4 Europe Gene-based Advanced Therapy Medicinal Market Size Growth (2017-2022)
4.5 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Growth (2017-2022)
5 Americas
5.1 Americas Gene-based Advanced Therapy Medicinal Market Size by Country (2017-2022)
5.2 Americas Gene-based Advanced Therapy Medicinal Market Size by Type (2017-2022)
5.3 Americas Gene-based Advanced Therapy Medicinal Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene-based Advanced Therapy Medicinal Market Size by Region (2017-2022)
6.2 APAC Gene-based Advanced Therapy Medicinal Market Size by Type (2017-2022)
6.3 APAC Gene-based Advanced Therapy Medicinal Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Gene-based Advanced Therapy Medicinal by Country (2017-2022)
7.2 Europe Gene-based Advanced Therapy Medicinal Market Size by Type (2017-2022)
7.3 Europe Gene-based Advanced Therapy Medicinal Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gene-based Advanced Therapy Medicinal by Region (2017-2022)
8.2 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Type (2017-2022)
8.3 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Gene-based Advanced Therapy Medicinal Market Forecast
10.1 Global Gene-based Advanced Therapy Medicinal Forecast by Regions (2023-2028)
10.1.1 Global Gene-based Advanced Therapy Medicinal Forecast by Regions (2023-2028)
10.1.2 Americas Gene-based Advanced Therapy Medicinal Forecast
10.1.3 APAC Gene-based Advanced Therapy Medicinal Forecast
10.1.4 Europe Gene-based Advanced Therapy Medicinal Forecast
10.1.5 Middle East & Africa Gene-based Advanced Therapy Medicinal Forecast
10.2 Americas Gene-based Advanced Therapy Medicinal Forecast by Country (2023-2028)
10.2.1 United States Gene-based Advanced Therapy Medicinal Market Forecast
10.2.2 Canada Gene-based Advanced Therapy Medicinal Market Forecast
10.2.3 Mexico Gene-based Advanced Therapy Medicinal Market Forecast
10.2.4 Brazil Gene-based Advanced Therapy Medicinal Market Forecast
10.3 APAC Gene-based Advanced Therapy Medicinal Forecast by Region (2023-2028)
10.3.1 China Gene-based Advanced Therapy Medicinal Market Forecast
10.3.2 Japan Gene-based Advanced Therapy Medicinal Market Forecast
10.3.3 Korea Gene-based Advanced Therapy Medicinal Market Forecast
10.3.4 Southeast Asia Gene-based Advanced Therapy Medicinal Market Forecast
10.3.5 India Gene-based Advanced Therapy Medicinal Market Forecast
10.3.6 Australia Gene-based Advanced Therapy Medicinal Market Forecast
10.4 Europe Gene-based Advanced Therapy Medicinal Forecast by Country (2023-2028)
10.4.1 Germany Gene-based Advanced Therapy Medicinal Market Forecast
10.4.2 France Gene-based Advanced Therapy Medicinal Market Forecast
10.4.3 UK Gene-based Advanced Therapy Medicinal Market Forecast
10.4.4 Italy Gene-based Advanced Therapy Medicinal Market Forecast
10.4.5 Russia Gene-based Advanced Therapy Medicinal Market Forecast
10.5 Middle East & Africa Gene-based Advanced Therapy Medicinal Forecast by Region (2023-2028)
10.5.1 Egypt Gene-based Advanced Therapy Medicinal Market Forecast
10.5.2 South Africa Gene-based Advanced Therapy Medicinal Market Forecast
10.5.3 Israel Gene-based Advanced Therapy Medicinal Market Forecast
10.5.4 Turkey Gene-based Advanced Therapy Medicinal Market Forecast
10.5.5 GCC Countries Gene-based Advanced Therapy Medicinal Market Forecast
10.6 Global Gene-based Advanced Therapy Medicinal Forecast by Type (2023-2028)
10.7 Global Gene-based Advanced Therapy Medicinal Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Gene-based Advanced Therapy Medicinal Product Offered
11.1.3 Biogen Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Gene-based Advanced Therapy Medicinal Product Offered
11.2.3 Novartis Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Gene-based Advanced Therapy Medicinal Product Offered
11.3.3 Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
11.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Product Offered
11.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Gene-based Advanced Therapy Medicinal Product Offered
11.6.3 Amgen Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
11.7.3 Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
11.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 Sunway Biotech
11.9.1 Sunway Biotech Company Information
11.9.2 Sunway Biotech Gene-based Advanced Therapy Medicinal Product Offered
11.9.3 Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Sunway Biotech Main Business Overview
11.9.5 Sunway Biotech Latest Developments
11.10 SIBIONO
11.10.1 SIBIONO Company Information
11.10.2 SIBIONO Gene-based Advanced Therapy Medicinal Product Offered
11.10.3 SIBIONO Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 SIBIONO Main Business Overview
11.10.5 SIBIONO Latest Developments
11.11 AnGes
11.11.1 AnGes Company Information
11.11.2 AnGes Gene-based Advanced Therapy Medicinal Product Offered
11.11.3 AnGes Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 AnGes Main Business Overview
11.11.5 AnGes Latest Developments
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Information
11.12.2 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
11.12.3 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Orchard Therapeutics Main Business Overview
11.12.5 Orchard Therapeutics Latest Developments
11.13 Human Stem Cells Institute
11.13.1 Human Stem Cells Institute Company Information
11.13.2 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Product Offered
11.13.3 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Human Stem Cells Institute Main Business Overview
11.13.5 Human Stem Cells Institute Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Gene-based Advanced Therapy Medicinal Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Viral Gene Delivery System
Table 3. Major Players of Non-viral Gene Delivery System
Table 4. Gene-based Advanced Therapy Medicinal Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Gene-based Advanced Therapy Medicinal Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2017-2022)
Table 7. Gene-based Advanced Therapy Medicinal Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Gene-based Advanced Therapy Medicinal Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2017-2022)
Table 10. Global Gene-based Advanced Therapy Medicinal Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Player (2020-2022)
Table 12. Gene-based Advanced Therapy Medicinal Key Players Head office and Products Offered
Table 13. Gene-based Advanced Therapy Medicinal Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene-based Advanced Therapy Medicinal Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Regions (2017-2022)
Table 18. Americas Gene-based Advanced Therapy Medicinal Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Gene-based Advanced Therapy Medicinal Market Size Market Share by Country (2017-2022)
Table 20. Americas Gene-based Advanced Therapy Medicinal Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2017-2022)
Table 22. Americas Gene-based Advanced Therapy Medicinal Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2017-2022)
Table 24. APAC Gene-based Advanced Therapy Medicinal Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Gene-based Advanced Therapy Medicinal Market Size Market Share by Region (2017-2022)
Table 26. APAC Gene-based Advanced Therapy Medicinal Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2017-2022)
Table 28. APAC Gene-based Advanced Therapy Medicinal Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2017-2022)
Table 30. Europe Gene-based Advanced Therapy Medicinal Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Gene-based Advanced Therapy Medicinal Market Size Market Share by Country (2017-2022)
Table 32. Europe Gene-based Advanced Therapy Medicinal Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2017-2022)
Table 34. Europe Gene-based Advanced Therapy Medicinal Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Gene-based Advanced Therapy Medicinal
Table 43. Key Market Challenges & Risks of Gene-based Advanced Therapy Medicinal
Table 44. Key Industry Trends of Gene-based Advanced Therapy Medicinal
Table 45. Global Gene-based Advanced Therapy Medicinal Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Gene-based Advanced Therapy Medicinal Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Gene-based Advanced Therapy Medicinal Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Gene-based Advanced Therapy Medicinal Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Gene-based Advanced Therapy Medicinal Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Gene-based Advanced Therapy Medicinal Market Size Market Share Forecast by Application (2023-2028)
Table 51. Biogen Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 52. Biogen Gene-based Advanced Therapy Medicinal Product Offered
Table 53. Biogen Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 57. Novartis Gene-based Advanced Therapy Medicinal Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Novartis Latest Developments
Table 61. Gilead Sciences Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 62. Gilead Sciences Gene-based Advanced Therapy Medicinal Product Offered
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Gilead Sciences Latest Developments
Table 66. Sarepta Therapeutics Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 67. Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
Table 68. Sarepta Therapeutics Main Business
Table 69. Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Sarepta Therapeutics Latest Developments
Table 71. Alnylam Pharmaceuticals Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 72. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Product Offered
Table 73. Alnylam Pharmaceuticals Main Business
Table 74. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Alnylam Pharmaceuticals Latest Developments
Table 76. Amgen Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 77. Amgen Gene-based Advanced Therapy Medicinal Product Offered
Table 78. Amgen Main Business
Table 79. Amgen Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Amgen Latest Developments
Table 81. Spark Therapeutics Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 82. Spark Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
Table 83. Spark Therapeutics Main Business
Table 84. Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Spark Therapeutics Latest Developments
Table 86. Akcea Therapeutics Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 87. Akcea Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
Table 88. Akcea Therapeutics Main Business
Table 89. Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Akcea Therapeutics Latest Developments
Table 91. Sunway Biotech Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 92. Sunway Biotech Gene-based Advanced Therapy Medicinal Product Offered
Table 93. Sunway Biotech Main Business
Table 94. Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Sunway Biotech Latest Developments
Table 96. SIBIONO Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 97. SIBIONO Gene-based Advanced Therapy Medicinal Product Offered
Table 98. SIBIONO Main Business
Table 99. SIBIONO Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. SIBIONO Latest Developments
Table 101. AnGes Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 102. AnGes Gene-based Advanced Therapy Medicinal Product Offered
Table 103. AnGes Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. AnGes Main Business
Table 105. AnGes Latest Developments
Table 106. Orchard Therapeutics Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 107. Orchard Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
Table 108. Orchard Therapeutics Main Business
Table 109. Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Orchard Therapeutics Latest Developments
Table 111. Human Stem Cells Institute Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 112. Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Product Offered
Table 113. Human Stem Cells Institute Main Business
Table 114. Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Human Stem Cells Institute Latest Developments
List of Figures
List of Figures
Figure 1. Gene-based Advanced Therapy Medicinal Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene-based Advanced Therapy Medicinal Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Type in 2021
Figure 7. Gene-based Advanced Therapy Medicinal in Neurological Diseases
Figure 8. Global Gene-based Advanced Therapy Medicinal Market: Neurological Diseases (2017-2022) & ($ Millions)
Figure 9. Gene-based Advanced Therapy Medicinal in Cancer
Figure 10. Global Gene-based Advanced Therapy Medicinal Market: Cancer (2017-2022) & ($ Millions)
Figure 11. Gene-based Advanced Therapy Medicinal in Other
Figure 12. Global Gene-based Advanced Therapy Medicinal Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Application in 2021
Figure 14. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Player in 2021
Figure 15. Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Gene-based Advanced Therapy Medicinal Market Size 2017-2022 ($ Millions)
Figure 17. APAC Gene-based Advanced Therapy Medicinal Market Size 2017-2022 ($ Millions)
Figure 18. Europe Gene-based Advanced Therapy Medicinal Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size 2017-2022 ($ Millions)
Figure 20. Americas Gene-based Advanced Therapy Medicinal Value Market Share by Country in 2021
Figure 21. Americas Gene-based Advanced Therapy Medicinal Consumption Market Share by Type in 2021
Figure 22. Americas Gene-based Advanced Therapy Medicinal Market Size Market Share by Application in 2021
Figure 23. United States Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Gene-based Advanced Therapy Medicinal Market Size Market Share by Region in 2021
Figure 28. APAC Gene-based Advanced Therapy Medicinal Market Size Market Share by Application in 2021
Figure 29. China Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Gene-based Advanced Therapy Medicinal Market Size Market Share by Country in 2021
Figure 36. Europe Gene-based Advanced Therapy Medicinal Market Size Market Share by Type in 2021
Figure 37. Europe Gene-based Advanced Therapy Medicinal Market Size Market Share by Application in 2021
Figure 38. Germany Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Market Share by Application in 2021
Figure 46. Egypt Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Gene-based Advanced Therapy Medicinal Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 52. APAC Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 53. Europe Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 55. United States Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 56. Canada Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 59. China Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 60. Japan Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 61. Korea Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 63. India Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 64. Australia Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 65. Germany Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 66. France Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 67. UK Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 68. Italy Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 69. Russia Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 70. Spain Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 73. Israel Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Gene-based Advanced Therapy Medicinal Market Size 2023-2028 ($ Millions)
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)